Characterization of a novel potent and specific inhibitor of type v phosphodiesterase
- 9 November 1995
- journal article
- research article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 50 (10) , 1577-1585
- https://doi.org/10.1016/0006-2952(95)02031-4
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Isolation of cyclic nucleotide phosphodiesterase isozymes from pig aortaBiochemical Pharmacology, 1993
- Haem-dependent activation of cytosolic guanylate cyclase by nitric oxide: a widespread signal transduction mechanismBiochemical Society Transactions, 1992
- Endothelium-derived nitric oxide: the endogenous nitrovasodilator in the human cardiovascular systemEuropean Heart Journal, 1991
- Characterisation of cyclic nucleotide phosphodiesterases from rat mesenteric arteryEuropean Journal of Pharmacology: Molecular Pharmacology, 1991
- Effects of selective phosphodiesterase inhibitors on isolated coronary, lung and renal arteries from man and ratActa Physiologica Scandinavica, 1991
- Desensitization of atriopeptin stimulated accumulation and extrusion of cyclic GMP from a kidney epithelial cell line (MDCK)Biochemical Pharmacology, 1991
- Characterization of cyclic nucleotide phosphodiesterases from cultured bovine aortic endothelial cellsBiochemical Pharmacology, 1990
- Selective inhibition of cyclic nucleotide phosphodiesterases of human, bovine and rat aortaBiochemical Pharmacology, 1986
- Endothelium-dependent relaxation in rat aorta may be mediated through cyclic GMP-dependent protein phosphorylationNature, 1983
- Purifieation of a Soluble, Sodium‐Nitroprusside‐Stimulated Guanylate Cyclase from Bovine LungEuropean Journal of Biochemistry, 1981